Tag Archives | DaVita HealthCare Partners

DaVita HealthCare – Written Consent

DaVita HealthCareDaVita HealthCare Partners Inc (NYSE:DVA), one of the companies in my portfolio, provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. Their annual meeting is coming up on June 20, 2016. I have a proposal on the proxy to allow shareholders to act by written consent.

ProxyDemocracy.org had collected the votes of three fund families when I checked. Vote AGAINST pay, committee, and proxy access ‘lite’; FOR the right to act by written consent. I voted with the Board’s recommendations 53% of the time. View Proxy Statement via iiWisdom.

Read Warnings below. What follows are my recommendations on how to vote the proxy in order to enhance corporate governance and long-term value. Continue Reading →

Continue Reading ·

DaVita HealthCare Partners: Proxy Score 50

DaVita HealthCare PartnersDaVita HealthCare Partners Inc (NYSE:DVA), one of the stocks in my portfolio, is a biopharmaceutical company focused on the development and commercialization of therapies to treat serious diseases for which there are limited treatment options. Their annual meeting is coming up on 6/16/2015. ProxyDemocracy.org had the vote of two funds when I checked and voted on 6/11/2015.  I voted with the board 50% of the time and assigned DaVita HealthCare Partners a proxy score of 50. Continue Reading →

Continue Reading ·

DaVita HealthCare Partners, DVA: Proxy Vote

DaVitaDaVita HealthCare Partners $DVA, is one of the stocks in my portfolio. Their annual meeting is June 17, 2014. ProxyDemocracy.org had collected the votes of three funds when I checked and voted on 6/10/2014.  I voted with management 50% of the time.  View Proxy Statement. Read Warnings below. What follows are my recommendations on how to vote the DVA proxy in order to enhance corporate governance and long-term value.   Continue Reading →

Continue Reading ·

Powered by WordPress. Designed by WooThemes